Drug Pipeline

Rocbrutinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07377578 A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With… Mantle Cell Lymphoma Recruiting
NCT07342478 ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R… CLL / SLL Recruiting
Phase 2
NCT05716087 A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma Mantle Cell Lymphoma (MCL) Active, Not Recruiting
Phase 1
NCT04775745 Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell… CLL/SLL Recruiting
NCT07570017 A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory… DLBCL Not Yet Recruiting
Sponsors Running Rocbrutinib Trials
Guangzhou Lupeng Pharmaceutical Company LTD. (3) Newave Pharmaceutical Inc (2)
Disease Areas
Mantle Cell Lymphoma (3) Leukemia (2) Chronic Lymphocytic Leukemia (CLL) (2) Follicular Lymphoma (1) DLBCL (1)
Get alerts when Rocbrutinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free